Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.
Kwadwo A KoramBright AduJosephine OcranYaa S KarikariSusan Adu-AmankwahMichael NtiriBenjamin AbuakuDaniel DodooBen GyanKarl C KronmannFrancis NkrumahPublished in: PloS one (2016)
ClinicalTrials.gov. Identifier: NCT01026246.